[Pediatric clinical experience in infectious endocarditis due to Candida spp]

Rev Chilena Infectol. 2018;35(5):553-559. doi: 10.4067/s0716-10182018000500553.
[Article in Spanish]

Abstract

Background: Treatment and outcome of Candida spp infectious endocarditis in children it most be based on treatment guidelines, however there are some controversies.

Aim: To describe our experience on treatment of pediatric candidal infective endocarditis.

Methods: Analytic prospective study, from January 2006 to December 2017. Parametric analysis for quantitative variable. Proportions were compared by χ2 and exact Fisher Test CI 95%. Mortality rate.

Results: 25 episodes of Candida spp infective endocarditis were treated with standard antifungal drugs. Mortality rate was higher on patients submited to endocardic vegetation resection (66.7%) RR= 3.16, (χ2 p = 0.029), children with lymphohemophagocytic syndrome (LHFS) (50 %) RR= 1.18 (χ2 = N.S.), in multidrug resistant bacterial co infection (57.14%), RR = 2, (χ2 = NS) also thrombotic endocarditis (88.9%) RR= 4.74 (χ2 p = 0.004).

Conclusion: Multidrug resistant bacteria co infection with Candida sp IE, LHFS, and/or surgical treatment of endocardic vegetation, might be considered as bad prognostic factors.

MeSH terms

  • Adolescent
  • Candida / classification*
  • Candidiasis / microbiology*
  • Candidiasis / mortality
  • Candidiasis / therapy
  • Child
  • Child, Preschool
  • Endocarditis, Bacterial / microbiology*
  • Endocarditis, Bacterial / mortality
  • Endocarditis, Bacterial / therapy
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Prospective Studies
  • Risk Factors